Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(6)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT01854229Not ApplicableCompleted

Prometra Post-Approval Study

Role: lead

NCT04096391Not ApplicableCompleted

Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population

Role: collaborator

NCT04312685Not ApplicableUnknown

Transitioning to a Valve -Gated Intrathecal Drug Delivery System

Role: collaborator

NCT04530955Not ApplicableUnknown

Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)

Role: collaborator

NCT03876158Phase 4Withdrawn

Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS)

Role: collaborator

NCT02578459Not ApplicableWithdrawn

A Pilot Study to Evaluate the Efficacy of ITDD vs. CMM in the Treatment of Pancreatic Cancer Pain

Role: lead

NCT01051128Phase 3Withdrawn

Continuous Intrathecal Baclofen Infusion for Chronic Spasticity

Role: lead

NCT00817596Not ApplicableCompleted

Prometra's Utilization in Mitigating Pain (PUMP)

Role: lead

NCT00866164Unknown

Prometra's Utilization in Mitigating Pain II

Role: lead

All 9 trials loaded